Slide background
Slide background
Slide background
Slide background
Slide background
Slide background
Slide background

GLA:D® Annual Report 2017

GLA:D Canada is pleased to announce the release of its 2017 Annual Report on the Implementation and Outcomes of the GLA:D Program in Canada.

The report summarizes the highlights from inception to December 2017 on the community-based education and exercise program for people with hip and knee osteoarthritis.

Some highlights include:

GLA:D Training and Site Implementation:

  • 14 courses for Health Care Providers (HCPs)
  • 61 sites implemented the program by December 2017 in 5 provinces

Key Findings:

  • 28% reduction in pain intensity
  • 35% of participants increased their physical activity


Patient Feedback

Patients who have gone through the GLA:D™ Canada program are invited to share their feedback with this short form.

GLA:D® is an education and exercise program developed by researchers in Denmark for individuals with hip or knee osteoarthritis symptoms. Research from the GLA:D® program in Denmark has shown a reduction in progression of symptoms by 27%. Other outcomes include a reduction in pain intensity, reduced use of joint related pain killers, and fewer individuals on sick leave. Program participants also reported high levels of satisfaction with the program and increased levels of physical activity 12 months after starting the program.

This program is unique in that the education and exercises provided can be applied to everyday activities. By strengthening and correcting daily movement patterns, participants will train their bodies to move properly, prevent symptom progression and reduce pain.

Osteoarthritis is the most common lifestyle disease in individuals 65 year of age and older. It is also prevalent in individuals between the ages of 30 and 45. Current national and international clinical guidelines recommend patient education, exercise and weight loss if necessary as treatment for osteoarthritis. In Canada, treatment focuses largely on surgery and does not follow best practice guidelines for treatment and management of osteoarthritic symptoms.


GLA:D® is an evidence-based program for treatment and management of osteoarthritic symptoms. GLA:D™ Canada is licensed to the Canadian Orthopaedic Foundation. It is currently being implemented by Bone and Joint Canada, a knowledge translation division of the Canadian Orthopaedic Foundation, with funding from the Ontario Trillium Foundation.